Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Rein Therapeutics Inc. (RNTX) had Cash Flow from Financial Activities of $17.82M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-62.88M |
|
-- |
|
-- |
|
$65.11M |
|
$-65.11M |
|
$0.69M |
|
$-64.43M |
|
$-64.43M |
|
$-62.88M |
|
$-62.88M |
|
$-62.88M |
|
$-62.88M |
|
$-65.11M |
|
$-28.05M |
|
17.94M |
|
17.94M |
|
$-3.51 |
|
$-3.51 |
|
| Balance Sheet Financials | |
$13.66M |
|
$0.00M |
|
$48.53M |
|
$62.19M |
|
$5.75M |
|
-- |
|
$47.05M |
|
$52.80M |
|
$9.39M |
|
$-39.14M |
|
$9.39M |
|
21.67M |
|
| Cash Flow Statement Financials | |
$-22.29M |
|
-- |
|
|
Cash Flow from Financial Activities |
$17.82M |
$17.34M |
|
$12.87M |
|
$-4.47M |
|
$1.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-669.89% |
|
160.65% |
|
-101.11% |
|
-669.89% |
|
$0.43 |
|
$-1.24 |
|
$-1.24 |
|